CliffBio
small molecule

DEXTROAMPHETAMINE SULFATE

DEXTROAMPHETAMINE SULFATE

Loss of exclusivity—loss of exclusivity
CompanySTRIDES PHARMA INTERNATIONAL AG

Drug detail

Brand nameDEXTROAMPHETAMINE SULFATE
Active ingredientDEXTROAMPHETAMINE SULFATE
Strength10MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2017
Marketing statusDISCN

More from STRIDES PHARMA INTERNATIONAL AG

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DEXTROAMPHETAMINE SULFATE patent cliff — loss of exclusivity — | CliffBio